MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase.
MLIP
cardiomyopathy
hyperCKemia
myopathy
rhabdomyolysis
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
22 10 2021
22 10 2021
Historique:
accepted:
14
06
2021
received:
19
12
2020
revised:
08
06
2021
pubmed:
29
9
2021
medline:
15
12
2021
entrez:
28
9
2021
Statut:
ppublish
Résumé
Striated muscle needs to maintain cellular homeostasis in adaptation to increases in physiological and metabolic demands. Failure to do so can result in rhabdomyolysis. The identification of novel genetic conditions associated with rhabdomyolysis helps to shed light on hitherto unrecognized homeostatic mechanisms. Here we report seven individuals in six families from different ethnic backgrounds with biallelic variants in MLIP, which encodes the muscular lamin A/C-interacting protein, MLIP. Patients presented with a consistent phenotype characterized by mild muscle weakness, exercise-induced muscle pain, variable susceptibility to episodes of rhabdomyolysis, and persistent basal elevated serum creatine kinase levels. The biallelic truncating variants were predicted to result in disruption of the nuclear localizing signal of MLIP. Additionally, reduced overall RNA expression levels of the predominant MLIP isoform were observed in patients' skeletal muscle. Collectively, our data increase the understanding of the genetic landscape of rhabdomyolysis to now include MLIP as a novel disease gene in humans and solidifies MLIP's role in normal and diseased skeletal muscle homeostasis.
Identifiants
pubmed: 34581780
pii: 6377325
doi: 10.1093/brain/awab275
pmc: PMC8536936
doi:
Substances chimiques
Co-Repressor Proteins
0
MLIP protein, mouse
0
Nuclear Proteins
0
Creatine Kinase
EC 2.7.3.2
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2722-2731Subventions
Organisme : CIHR
ID : MOP119470
Pays : Canada
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Published by Oxford University Press on behalf of the Guarantors of Brain 2021.
Références
Neuromuscul Disord. 2013 Feb;23(2):116-9
pubmed: 23177318
J Neurol. 2020 Apr;267(4):877-882
pubmed: 30617905
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19254-19265
pubmed: 32719146
Neuropediatrics. 1998 Apr;29(2):97-101
pubmed: 9638664
Cells. 2021 Mar 10;10(3):
pubmed: 33802236
Pract Neurol. 2018 Feb;18(1):14-26
pubmed: 29223996
Pediatr Nephrol. 2017 Dec;32(12):2273-2282
pubmed: 28779239
J Biol Chem. 2011 Jun 3;286(22):19702-13
pubmed: 21498514
PLoS One. 2017 Mar 15;12(3):e0172995
pubmed: 28296976
Am J Hum Genet. 2016 Feb 4;98(2):358-62
pubmed: 26805782
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
Can J Neurol Sci. 2018 May;45(3):262-268
pubmed: 29382405
J Biol Chem. 2018 Dec 21;293(51):19761-19770
pubmed: 30389785
J Clin Invest. 2015 Nov 2;125(11):4122-34
pubmed: 26436652
Orphanet J Rare Dis. 2015 May 02;10:51
pubmed: 25929793
J Biol Chem. 2015 Oct 30;290(44):26699-714
pubmed: 26359501